Role of AI in Biomedical Research and Pharmaceutical Development

Abstract

Artificial Intelligence (AI) is rapidly transforming modern healthcare, biomedical research, and pharmaceutical development by enabling the analysis of large and complex datasets. AI technologies, including machine learning (ML), natural language processing (NLP), and generative AI, are increasingly used to accelerate drug discovery, optimize clinical trials, and support pharmaceutical innovation. These technologies assist researchers in identifying therapeutic targets, predicting drug–target interactions, performing virtual drug screening, and repurposing existing medications. AI has also played a significant role in vaccine development, particularly during the COVID-19 pandemic, by facilitating genetic sequence analysis and accelerating vaccine design. In addition, AI-driven applications improve patient engagement and treatment adherence through personalized health monitoring, automated reminders, and digital health platforms. In rehabilitation, AI-supported robotics, wearable technologies, and smart systems enhance patient recovery by monitoring movement, providing feedback, and enabling remote therapy. Furthermore, AI tools such as chatbots and digital assistants support mental health communication and patient education. Administrative healthcare processes also benefit from AI through automated data extraction, clinical documentation, and robotic process automation, which reduce workload for healthcare professionals. Despite these advantages, challenges such as data privacy, ethical concerns, technological limitations, and patient acceptance remain critical considerations. Overall, AI holds significant potential to improve healthcare outcomes, increase efficiency, and support innovation in medical research and clinical practice.